<!DOCTYPE HTML>
<!--
  Theory by TEMPLATED
  templated.co @templatedco
  Released for free under the Creative Commons Attribution 3.0 license (templated.co/license)
-->
<html>
  <head>
    <title>Combination Therapies</title>
    <meta charset="utf-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1" />
    <link rel="stylesheet" href="assets/css/main.css" />
  </head>
  <body>

    <!-- Header -->
      <header id="header">
        <div class="inner">
          <!--<a href="index.html" class="logo">Home</a>-->
          <nav id="nav">
            <!--<a href="contact.html">Contact</a>-->
          </nav>
          <a href="#navPanel" class="navPanelToggle"><span class="fa fa-bars"></span></a>
        </div>
      </header>

    <!-- Banner -->
      <section id="banner">
        <h1>Combination Therapies for Cancer Treatment</h1>
        <a style='border-radius:.2em;' class='button special' href="https://app.smartsheet.com/b/form/8cb3788f57344ee9adb244d69acde60f" target="_blank">Apply easily to one or more microlabs >></a>
      </section>

    <!-- One -->
      <section id="one" class="wrapper">
        <div class="inner">
          <article>
            <p><a href="http://apply.hub.ki/combotherapies/">ðŸ ” Return Home</a></p>
            <h3 style="font-size:2rem;">Micro Lab #4 - Moving from Experimental Success to Clinical Reality</h3>
            <span style="font-size:12pt;font-family:Calibri,sans-serif;color:#000000;background-color:transparent;font-weight:700;font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre;white-space:pre-wrap;">Date/Time</span><span style="font-size:12pt;font-family:Calibri,sans-serif;color:#000000;background-color:transparent;font-weight:400;font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre;white-space:pre-wrap;">: September 30, 2021, from 11AM to 2PM EST.</span><p dir="ltr" style="line-height:1.2;margin-top:0pt;margin-bottom:0pt;"><span style="font-size:12pt;font-family:Calibri,sans-serif;color:#000000;background-color:transparent;font-weight:400;font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre;white-space:pre-wrap;">There are many promising drug combinations resulting from computational or in vitro assays that fail to translate to the clinic. The reasons can be diverse and include toxicity but also PK and factors that are patient-specific. Is it possible to incorporate this information earlier in the process? We will discuss this and other questions including but not limited to:&nbsp;</span></p><br><ul style="margin-top:0;margin-bottom:0;padding-inline-start:48px;"><li dir="ltr" style="list-style-type:disc;font-size:12pt;font-family:'Noto Sans Symbols',sans-serif;color:#000000;background-color:transparent;font-weight:400;font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre;margin-left: -18.75pt;" aria-level="1"><p dir="ltr" style="line-height:1.295;margin-top:0pt;margin-bottom:0pt;" role="presentation"><span style="font-size:12pt;font-family:Calibri,sans-serif;color:#000000;background-color:transparent;font-weight:400;font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre;white-space:pre-wrap;">How should cell toxicity and side effects balance therapeutic efficiency?</span></p></li><li dir="ltr" style="list-style-type:disc;font-size:12pt;font-family:'Noto Sans Symbols',sans-serif;color:#000000;background-color:transparent;font-weight:400;font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre;margin-left: -18.75pt;" aria-level="1"><p dir="ltr" style="line-height:1.295;margin-top:0pt;margin-bottom:0pt;" role="presentation"><span style="font-size:12pt;font-family:Calibri,sans-serif;color:#000000;background-color:transparent;font-weight:400;font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre;white-space:pre-wrap;">Can we explain synergistic differences between toxicity and efficacy?&nbsp;</span></p></li><li dir="ltr" style="list-style-type:disc;font-size:12pt;font-family:'Noto Sans Symbols',sans-serif;color:#000000;background-color:transparent;font-weight:400;font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre;margin-left: -18.75pt;" aria-level="1"><p dir="ltr" style="line-height:1.295;margin-top:0pt;margin-bottom:0pt;" role="presentation"><span style="font-size:12pt;font-family:Calibri,sans-serif;color:#000000;background-color:transparent;font-weight:400;font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre;white-space:pre-wrap;">How does heterogeneity of the patient population hinder or help these predictions?</span></p></li><li dir="ltr" style="list-style-type:disc;font-size:12pt;font-family:'Noto Sans Symbols',sans-serif;color:#000000;background-color:transparent;font-weight:400;font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre;margin-left: -18.75pt;" aria-level="1"><p dir="ltr" style="line-height:1.295;margin-top:0pt;margin-bottom:8pt;" role="presentation"><span style="font-size:12pt;font-family:Calibri,sans-serif;color:#000000;background-color:transparent;font-weight:400;font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre;white-space:pre-wrap;">What experimental systems can be used to predict the toxicity/efficacy trade-off?</span></p></li></ul><p dir="ltr" style="line-height:1.295;margin-top:0pt;margin-bottom:0pt;"><span style="font-size:12pt;font-family:Calibri,sans-serif;color:#000000;background-color:transparent;font-weight:700;font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre;white-space:pre-wrap;">Speakers:&nbsp;</span></p><p dir="ltr" style="line-height:1.295;margin-top:0pt;margin-bottom:0pt;"><span style="font-size:12pt;font-family:Calibri,sans-serif;color:#000000;background-color:transparent;font-weight:400;font-style:normal;font-variant:normal;text-decoration:underline;-webkit-text-decoration-skip:none;text-decoration-skip-ink:none;vertical-align:baseline;white-space:pre;white-space:pre-wrap;">Clinical perspective</span><span style="font-size:12pt;font-family:Calibri,sans-serif;color:#000000;background-color:transparent;font-weight:400;font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre;white-space:pre-wrap;">: Sadhana Jackson, NIH</span></p><p dir="ltr" style="line-height:1.295;margin-top:0pt;margin-bottom:0pt;"><span style="font-size:12pt;font-family:Calibri,sans-serif;color:#000000;background-color:transparent;font-weight:400;font-style:normal;font-variant:normal;text-decoration:underline;-webkit-text-decoration-skip:none;text-decoration-skip-ink:none;vertical-align:baseline;white-space:pre;white-space:pre-wrap;">Cancer biology perspective</span><span style="font-size:12pt;font-family:Calibri,sans-serif;color:#000000;background-color:transparent;font-weight:400;font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre;white-space:pre-wrap;">: (TBC)</span></p><p dir="ltr" style="line-height:1.295;margin-top:0pt;margin-bottom:0pt;"><span style="font-size:12pt;font-family:Calibri,sans-serif;color:#000000;background-color:transparent;font-weight:400;font-style:normal;font-variant:normal;text-decoration:underline;-webkit-text-decoration-skip:none;text-decoration-skip-ink:none;vertical-align:baseline;white-space:pre;white-space:pre-wrap;">Computational modeling perspective:</span><span style="font-size:12pt;font-family:Calibri,sans-serif;color:#000000;background-color:transparent;font-weight:400;font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre;white-space:pre-wrap;"> Joseph Szustakowski, Bristol Myers Squibb</span></p>
            <br><a style='border-radius:.2em;' class='button special' href="https://app.smartsheet.com/b/form/8cb3788f57344ee9adb244d69acde60f" target="_blank">Apply now >></a><br>
            <br><br><p><a href="http://apply.hub.ki/combotherapies/">ðŸ ” Return Home</a></p>
          </article>
        </div>
      </section>



     

    <!-- Footer -->
      <footer id="footer">
        <div class="inner">
          <div class="flex">
            <div class="copyright">
              &copy; Untitled. Design: <a href="https://templated.co">TEMPLATED</a>. Images: <a href="https://unsplash.com">Unsplash</a>.
            </div>
            <!--<ul class="icons">
              <li><a href="#" class="icon fa-facebook"><span class="label">Facebook</span></a></li>
              <li><a href="#" class="icon fa-twitter"><span class="label">Twitter</span></a></li>
              <li><a href="#" class="icon fa-linkedin"><span class="label">linkedIn</span></a></li>
              <li><a href="#" class="icon fa-pinterest-p"><span class="label">Pinterest</span></a></li>
              <li><a href="#" class="icon fa-vimeo"><span class="label">Vimeo</span></a></li>
            </ul>-->
          </div>
        </div>
      </footer>

    <!-- Scripts -->
      <script src="assets/js/jquery.min.js"></script>
      <script src="assets/js/skel.min.js"></script>
      <script src="assets/js/util.js"></script>
      <script src="assets/js/main.js"></script>
      <script src="assets/js/show-full-bio.js"></script>

  </body>
</html>
